NeoSoma
Neosoma provides a comprehensive neuro-oncology SaaS solution that transforms brain cancer care by offering AI-driven insights from MRI interpretation. Their patented, FDA-cleared technology delivers quantitative imaging biomarkers, longitudinal disease assessment, and centralized document management for a unified neuro-oncology team. Neosoma aims to improve clinical decisions, enhance patient outcomes, and increase the efficiency and accuracy of clinical trials by providing objective data and insights that were previously inaccessible through manual analysis. They collaborate with leading clinical sites and have published research demonstrating the predictive value of their AI analysis for brain cancer survival.
NeoSoma
Neosoma provides a comprehensive neuro-oncology SaaS solution that transforms brain cancer care by offering AI-driven insights from MRI interpretation. Their patented, FDA-cleared technology delivers quantitative imaging biomarkers, longitudinal disease assessment, and centralized document management for a unified neuro-oncology team. Neosoma aims to improve clinical decisions, enhance patient outcomes, and increase the efficiency and accuracy of clinical trials by providing objective data and insights that were previously inaccessible through manual analysis. They collaborate with leading clinical sites and have published research demonstrating the predictive value of their AI analysis for brain cancer survival.